Reardon Tighe
Janux Therapeutics, Inc. · Acting Chief Financial Officer
Reardon Tighe serves as the Acting Chief Financial Officer at Janux Therapeutics, Inc., a company focused on innovative therapies in the healthcare sector. His recent insider trading activity, tracked through SEC Form 4 filings, reflects a total of four disclosures from November 15, 2023, to June 5, 2024. This includes notable sale and purchase activities, with the largest disclosed move being a sale valued at approximately $37.9 million on June 5, 2024.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $38M691.5k shares | SellJun 3, 2024 | $54.75 | $15.25 | |
| $7M131.2k shares | SellJun 3, 2024 | $54.75 | $15.25 |